FindTrial
Sign In

Genotype and significance of HBV /HCV in patients with liver cirrhosis in Jining

Genotype and significance of HBV /HCV in patients with liver cirrhosis in Jining

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-12002024
Enrollment
Unknown
Registered
2012-03-19
Start date
2012-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis with HBV /HCV

Interventions

A:HBV(+)
B:HBV (+)

Sponsors

Department of Gastroenterology and Hepatology, Affiliated Hospital of Jining Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with liver cirrhosis diagnosed clearly; 2. Good compliance to doctors.

Exclusion criteria

Exclusion criteria: no

Design outcomes

Primary

MeasureTime frame
genotype of HBV and HCV;—

Countries

China

Contacts

Public ContactLiu Yang
ly5612209@188.com+86 15264745590

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026